Although the superiority in PFS in the irAE group tended to attenuate at later landmark time points, a favorable trend was consistently observed across all analyses compared with the non‐irAE group.
← all excerpts
Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study.
1
—
—